Websites on screening for breast cancer:Not all advocacy groups receive industry funding

BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7442.769-c (Published 25 March 2004) Cite this as: BMJ 2004;328:769
  1. Georgana Hanson, clearinghouse coordinator (ghanson{at}nwhn.org)
  1. National Women's Health Network, Washington, DC 20004, USA

    EDITOR—Jørgensen and Gøtzsche explored the relation between corporate funding and the presentation and dissemination of health information.1 As an organisation dedicated to providing a critical analysis of women's health issues, the National Women's Health Network recognises the important influence such funding can have over those who provide consumers and policy makers with health information.

    I would, however, like to comment on and correct how the National Women's Health Network was categorised in the study. The authors placed us in the advocacy group category: “general purpose is to promote the interests of patients and their relatives.” Although we are an advocacy group, we are also a consumer group: “general aim is to assess the quality of the health care services that are offered to patients and citizens.” We are something of a hybrid and can be difficult to categorise.

    I am concerned, however, that the authors said that all 13 advocacy groups included in the study accepted industry funding. The National Women's Health Network has maintained a strict “no industry” funding policy since its inception in 1975. This policy has allowed the network to remain independent and has earned us a reputation as one of the few organisations that provide accurate and reliable information on women's health, free from industry influence.


    • Competing interests None declared


    View Abstract

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial